A new study shows the effectiveness and safety of fecal microbiota transplantation for treating Clostridium difficle, according to a Medscape report.
The study eases concerns about using fecal transplants in patients with compromised immune systems, for which supporting guidelines and data did not previously exist.
Lead researcher Chioma Ihunnah, MD, of Brown University in Providence, R.I., and her team found the cure rate of C. diff with a single fecal transplant to be 79 percent, which rose to 89 percent after a second transplant.
More Articles on Gastroenterology:
IBD Sufferers Often Have Limited Access to Care
Olympus Medical to Launch Updated Ultrasound Endoscopy Center in November
South Jersey Endoscopy Center Purchases HET System for Hemorrhoid Treatment
The study eases concerns about using fecal transplants in patients with compromised immune systems, for which supporting guidelines and data did not previously exist.
Lead researcher Chioma Ihunnah, MD, of Brown University in Providence, R.I., and her team found the cure rate of C. diff with a single fecal transplant to be 79 percent, which rose to 89 percent after a second transplant.
More Articles on Gastroenterology:
IBD Sufferers Often Have Limited Access to Care
Olympus Medical to Launch Updated Ultrasound Endoscopy Center in November
South Jersey Endoscopy Center Purchases HET System for Hemorrhoid Treatment